Research programme: Genitourinary and Kidney disorder therapeutics - Pivot PharmaceuticalsAlternative Names: PVT 002; PVT 003
Latest Information Update: 30 Dec 2015
At a glance
- Originator Pivot Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Genitourinary disorders; Kidney disorders
Most Recent Events
- 30 Dec 2015 Preclinical trials in Kidney disorders in USA (unspecified route)
- 30 Dec 2015 Preclinical trials in Genitourinary disorders in USA (unspecified route)